New mRNA flu shot shows promise in phase 2 trial
NCT ID NCT06431607
First seen Jan 04, 2026 · Last updated May 07, 2026 · Updated 21 times
Summary
This study tested a new mRNA-based seasonal flu vaccine from GSK in 845 healthy adults aged 18 to 85. The goal was to find the best dose and check how well it triggers the immune system and how safe it is. Results will help decide if the vaccine should move into larger trials.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA, HUMAN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSK Investigational Site
Hialeah, Florida, 33012, United States
-
GSK Investigational Site
Miami, Florida, 33147, United States
-
GSK Investigational Site
Miami, Florida, 33186, United States
-
GSK Investigational Site
Chicago, Illinois, 60640, United States
-
GSK Investigational Site
Valparaiso, Indiana, 46383, United States
-
GSK Investigational Site
El Dorado, Kansas, 67042, United States
-
GSK Investigational Site
Lenexa, Kansas, 66219, United States
-
GSK Investigational Site
Newton, Kansas, 67114, United States
-
GSK Investigational Site
Wichita, Kansas, 67207, United States
-
GSK Investigational Site
Lexington, Kentucky, 40509, United States
-
GSK Investigational Site
Rochester, New York, 14609, United States
-
GSK Investigational Site
Greensboro, North Carolina, 27408, United States
-
GSK Investigational Site
Knoxville, Tennessee, 37909, United States
-
GSK Investigational Site
Austin, Texas, 78705, United States
-
GSK Investigational Site
Fort Worth, Texas, 76135, United States
-
GSK Investigational Site
Tomball, Texas, 77375, United States
-
GSK Investigational Site
Newport News, Virginia, 23606, United States
-
GSK Investigational Site
Norfolk, Virginia, 23502, United States
Conditions
Explore the condition pages connected to this study.